10-Nov-2010 - API maker AMRI cited arbitration costs, efforts to address a US FDA warning letter and acquisitions as key factors in Q3 loss, but predicted that large-scale contract manufacturing business will drive final quarter gains.
10-Nov-2010 - In the 20 month period before the heparin crisis no Chinese producers were inspected by the FDA and efforts during and since have been hindered by legal and practical challenges.
03-Nov-2010 - in-PharmaTechnologist presents interactive charts visualising FDA overseas inspections by type and year, as well as the proportion of sites that may never have been inspected.
28-Oct-2010 - Overseas FDA offices have realised immediate benefits but strategic planning is needed to ensure the ventures, critical aspects of the agency’s ability to ensure drug quality, are long-term successes according to the GAO.
27-Oct-2010 - The FDA may never have inspected 88 per cent of the 920 Chinese facilities in its inventory, according to the GAO.
20-Oct-2010 - Eli Lilly has unveiled plans to close its Singapore R&D centre by the end of the year and relocate discovery operations to its global headquarters in the US.
18-Oct-2010 - IDT Biologika.says demand for vaccines in emerging markets is big chance for Big Pharma and hence a growing niche for contractors with the technical capabilities to carry out such work.
14-Oct-2010 - Biopharm sees a large future for packaging containing digital codes that can link mobile devices to content, according to Catalent.
14-Oct-2010 - Stemedica and AnC Bio have formed a joint venture to manufacture stem cells for the treatment of ischemic stroke and other degenerative disorders.
13-Oct-2010 - Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.
13-Oct-2010 - Pharmatek Laboratories has once again expanded service offerings at its San Diego, California facility by adding two roller compactors to its solid oral dosage form manufacturing capabilities.
30-Sep-2010 - Zydus Nycomed expects commercial production at its newly commissioned API plant in Navi Mumbai, India to begin in December 2010.
29-Sep-2010 - HUYA Bioscience International will co-develop a new Chinese cancer drug, HBI-8000, with Quintiles for the “benefit of cancer patients globally.”
23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.
22-Sep-2010 - IDT Biologika unveils plans to expand viral vaccine contract manufacturing operations and says global capacity failing to keep pace with resurgence in drug industry demand.
20-Sep-2010 - Life Technologies has concluded license agreements, providing rights to its proprietary Chinese hamster ovary (CHO) cell lines for production of recombinant proteins used as therapeutic agents and vaccines.
16-Sep-2010 - Rexam and Med Time Technology, a US manufacturer of plastic prescription vials, have launched “Pill Timer,” a packaging solution designed to boost treatment compliance rates.
14-Sep-2010 - Industrial catalysis firm WR Grace moves for struggling Synthetech to boost pharmaceutical intermediates and chiral chemistry offering.
13-Sep-2010 - Genzyme has confirmed plans to sell genetic testing unit to LabCorp for $925m amid media rumours that 1,000 employees face redundancy.
09-Sep-2010 - Bend Research is bolstering its hot-melt extrusion service capabilities by installing new equipment at its contract manufacturing site.
08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.
07-Sep-2010 - DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has announced the launch of InnoSyn route scouting services, meeting pharma needs to outsource process development R&D.
07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.
06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.
06-Sep-2010 - Aurobindo Pharma is to supply AstraZeneca with solid dosage and sterile generic products for sale in emerging products.